USE OF METRONIDAZOLE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR TREATING PATHOLOGIES RELATED TO THE B-TYPE RECEPTOR OF INTERLEUKIN 8 AND/OR TO A PACAP TYPE 1 RECEPTOR

摘要

The invention relates to the use of metronidasole for preparing a pharmaceutical composition for treating pathologies involving at least one B-type receptor selected in a group containing an IL-8RB receptor and a PAC-1 receptor.